STATE MANDATED
Meet Several of Your Alabama CME/CE Requirements
We've outlined your Alabama CME/CE requirements and curated a variety of primary care courses to help fulfill them. View Alabama CME/CE courses for physicians, nurse practitioners, and physician assistants below. Simply create your free account and begin earning credits today!
Alabama CME/CE Requirements
(2) hours on controlled substance prescribing practices, recognizing signs of the abuse or misuse of controlled substances, or controlled substance prescribing for pain management (for ASCS registrants).
(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.
For more information:
https://www.albme.gov/resources/licensees/continuing-medical-education/qacsc-cme-requirement.
(12) hours on controlled substance prescribing practices and pharmacology (initial QACSC registrant);
(4) hours on advanced pharmacology and prescribing trends (through Board-approved course).
(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.
For more information:
https://www.abn.alabama.gov/licensing/advanced-practice/
https://www.albme.gov/licensing/crnp-cnm/qacsc/
(8) hours on controlled substance prescribing practices and pharmacology (through Board-specified course, for initial QASCS registrants);
(4) hours on advanced pharmacology and prescribing trends (through Board-approved course).
(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.
For more information:
https://www.albme.gov/resources/licensees/continuing-medical-education/qacsc-cme-requirement